Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

<p>Abstract</p> <p>Background</p> <p>As a member of the TNF superfamily, TRAIL could induce human tumor cell apoptosis through its cognate death receptors DR4 or DR5, which can induce formation of the death inducing signaling complex (DISC) and activation of the membran...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Qiao Chunxia, Hu Meiyun, Guo Leiming, Lv Ming, Lin Zhou, Geng Jing, Lang Xiaoling, Li Xinying, Li Yan, Ma Yuanfang, Feng Jiannan, Shen Beifen
Format:	Article
Sprog:	English
Udgivet:	BMC 2012-07-01
Serier:	BMC Immunology
Fag:	TRAIL Death receptor 5 Monoclonal antibody Apoptosis Breast cancer
Online adgang:	http://www.biomedcentral.com/1471-2172/13/40

Lignende værker

Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia
af: Min Cui, et al.
Udgivet: (2010-08-01)

Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury
af: Danyang Zhao, et al.
Udgivet: (2023-05-01)

Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling
af: Xiao Tian, et al.
Udgivet: (2024-02-01)

Macrophage-like THP-1 Cells Derived from High-Density Cell Culture Are Resistant to TRAIL-Induced Cell Death via Down-Regulation of Death-Receptors DR4 and DR5
af: Yana Vladimirovna Lomovskaya, et al.
Udgivet: (2022-01-01)

Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
af: Xinran Qiao, et al.
Udgivet: (2018-07-01)

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
af: Agathe Dubuisson, et al.
Udgivet: (2017-10-01)

Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression
af: Seok Kim, et al.
Udgivet: (2018-07-01)

CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide
af: Jayaprakasam Madhumathi, et al.
Udgivet: (2017-03-01)

Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature
af: Zakareya Gamie, et al.
Udgivet: (2024-09-01)

Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells
af: Seon Min Woo, et al.
Udgivet: (2020-10-01)

Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells
af: Jeong Mi Yun, et al.
Udgivet: (2018-09-01)

Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5
af: Juan LI, et al.
Udgivet: (2017-02-01)

Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP
af: Mi-Yeon Jeon, et al.
Udgivet: (2018-11-01)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
af: Taiga Seki, et al.
Udgivet: (2021-11-01)

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
af: de Vries Elisabeth GE, et al.
Udgivet: (2011-01-01)

Amphiphilic Poly(<i>N</i>-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells
af: Anne Yagolovich, et al.
Udgivet: (2021-09-01)

Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation
af: Catrin Heim, et al.
Udgivet: (2024-06-01)

DR5‐Cbl‐b/c‐Cbl‐TRAF2 complex inhibits TRAIL‐induced apoptosis by promoting TRAF2‐mediated polyubiquitination of caspase‐8 in gastric cancer cells
af: Ling Xu, et al.
Udgivet: (2017-12-01)

Landscape space 5 : walking space
Udgivet: ([200)

Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4
af: Ismael Obaidi, et al.
Udgivet: (2020-05-01)

First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
af: Feng Wang, et al.
Udgivet: (2021-07-01)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
af: Anne V. Yagolovich, et al.
Udgivet: (2020-04-01)

Urban trails : a preliminary list of trails and sources/
af: 409605 Goodey, Brian
Udgivet: (1974)

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
af: Mongkolsapaya, J, et al.
Udgivet: (1999)

The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients.
af: Magdalena Marcinczyk, et al.
Udgivet: (2008-06-01)

Combination of oridonin and TRAIL induces apoptosis in uveal melanoma cells by upregulating DR5
af: Xin Hua, et al.
Udgivet: (2021-12-01)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
af: Khuri Fadlo R, et al.
Udgivet: (2010-01-01)

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
af: Artem A. Artykov, et al.
Udgivet: (2021-09-01)

Planning for urban trails/
af: 8697 American Society of Planning Officials, et al.
Udgivet: (1969)

“Wild” Generosity: The Role of Trail Angels in Shaping Community on America’s Long-Distance Hiking Trails
af: Kristi McLeod
Udgivet: (2024-07-01)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
af: Artem A. Artykov, et al.
Udgivet: (2022-02-01)

Selective targeting of DR5 circumvents resistance of MG-63 osteosarcoma to trail-induced apoptosis
af: Locklin, R, et al.
Udgivet: (2006)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
af: Barbara Toffoli, et al.
Udgivet: (2021-11-01)

‘Standing on the Shoulders of the Giants’: Dr. Robert Kyle
af: Mohamad Mohty, et al.
Udgivet: (2022-11-01)

Traals for the twenty-first century : planning, design, and managemant manual for multi use-trails /
af: Ryan, Karen-Lee
Udgivet: (1993)

Trailing TRAIL Resistance: Novel Targets for TRAIL sensitization in Cancer cells
af: RACHANA eTRIVEDI, et al.
Udgivet: (2015-04-01)

OBSERVATIONAL TRAILS IN LIPIDOLOGY
af: S. A. Shalnova
Udgivet: (2016-01-01)

Long-lived meteor trails
af: Mikhalev A.V., et al.
Udgivet: (2019-09-01)

TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression.
af: Fang Fang Liu, et al.
Udgivet: (2014-01-01)

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
af: Dongjin Jeong, et al.
Udgivet: (2021-07-01)